We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Implanted Fistula Device Lowers Blood Pressure

By HospiMedica International staff writers
Posted on 05 Feb 2015
Print article
Image: The Rox Coupler (Photo courtesy of Rox Medical).
Image: The Rox Coupler (Photo courtesy of Rox Medical).
An innovative vascular coupling device tackles resistant high blood pressure (BP) by joining an artery and a vein together in the groin.

Researchers at Queen Mary, University of London (QMUL; United Kingdom), the Wales Heart Research Institute (Cardiff, United Kingdom), and other institutions conducted a randomized, blinded endpoint clinical trial of the efficacy of the Rox coupler, a paper-clip sized implant which is inserted between the artery and vein in the upper thigh, creating a partial anastomosis. The study involved 83 patients from 16 European centers, all of whom had resistant high blood pressure and had not responded to at least three types of drug treatment.

The results showed that the 44 patients who received the Coupler experienced a significant (26.9%) and durable reduction in blood pressure, as well as a reduced number of hypertensive complications and hospital admissions for high blood pressure crises. The Coupler also worked well among patients who had failed to respond to renal denervation, suggesting that it targets different mechanisms of BP control. An unwanted side effect, however, was leg swelling, with 29% of patients who received the Coupler requiring a stent. The study was published on January 22, 2015, in the Lancet.

“This is an entirely new and highly promising concept in high blood pressure treatment. The Coupler effectively targets the mechanical aspects of how blood circulation works, so it's a totally new approach to controlling blood pressure,” said lead author Melvin Lobo, MD, of QMUL. “The Coupler also highlights the importance of arterial stiffness as a major cause of resistant high blood pressure and it targets this issue both safely and successfully. Once the Coupler is placed, the results are also immediate, which again is unique to this treatment.”

The Rox coupler is a small metal stent made of nickel-titanium (nitinol) which forms an anastomosis between venous and arterial iliac vessels, allowing blood to flow between the high pressure artery and the low pressure vein. The device is inserted and positioned via a laparoscopic procedure at the groin under local anesthesia, and is fully reversible by placing a covered stent over the arterial side of the anastomosis. The Rox coupler is a product of Rox Medical (San Clemente, CA, USA).

Related Links:

Queen Mary, University of London
Wales Heart Research Institute
Rox Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Surgical Techniques

view channel
Image: The tiny, flexible devices can wrap around individual nerve fibers without damaging them (Photo courtesy of 123RF)

Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions

Electric nerve implants serve dual functions: they can either stimulate or block signals in specific nerves. For example, they may alleviate pain by inhibiting pain signals or restore movement in paralyzed... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.